Woodley Farra Manion Portfolio Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-413
Closed -$32K 202
2020
Q2
$32K Hold
413
﹤0.01% 195
2020
Q1
$31K Sell
413
-535
-56% -$37K ﹤0.01% 194
2019
Q4
$62K Buy
+948
New +$61.7K 0.01% 167
2019
Q3
Sell
-3,720
Closed -$251K 77
2019
Q2
$251K Sell
3,720
-2,610
-41% -$172K 0.03% 74
2019
Q1
$412K Sell
6,330
-333,258
-98% -$22.2M 0.04% 65
2018
Q4
$21.2M Sell
339,588
-25,952
-7% -$1.81M 2.58% 23
2018
Q3
$28.2M Buy
365,540
+1,350
+0.4% +$102K 2.92% 20
2018
Q2
$25.8M Buy
364,190
+5,777
+2% +$408K 2.88% 22
2018
Q1
$27M Buy
358,413
+156,855
+78% +$12.5M 3.05% 20
2017
Q4
$14.4M Sell
201,558
-20,926
-9% -$1.59M 1.59% 25
2017
Q3
$18M Buy
+222,484
New +$17M 2.09% 25

Other funds holding GILD

Woodley Farra Manion Portfolio Management's GILD Position: Q3 2020 in Review

Woodley Farra Manion Portfolio Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 413 shares — an estimated $32K sold.

Woodley Farra Manion Portfolio Management first reported a position in GILD in Q3 2017 and held it in 11 quarters. The position peaked at $28.2M in Q3 2018. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Woodley Farra Manion Portfolio Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 413 Gilead Sciences shares in Q3 2020, an estimated $32K.
  • Woodley Farra Manion Portfolio Management first reported a position in Gilead Sciences in Q3 2017 and held it in 11 quarters.
  • Woodley Farra Manion Portfolio Management's Gilead Sciences position peaked at $28.2M in Q3 2018.
  • 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q3 2020, filed 5 Nov 2020.